Bowyer Research has issued a notice of exempt solicitation to The Walt Disney Company's shareholders, urging them to vote in favor of a proposal by the National Legal and Policy Center on Disney's 2024 proxy ballot. The proposal calls for a report by December 31, 2024, detailing compensation and health benefit gaps, specifically addressing care related to gender dysphoria and de-transitioning across gender classifications. It also seeks to highlight the associated risks in terms of reputation, competition, operations, and talent recruitment and retention. Bowyer Research criticizes Disney's current stance on gender-affirming care, suggesting that it mischaracterizes the concerns raised and may lead to significant risks, including litigation from employees who regret transition treatments. The solicitation emphasizes the need for Disney to seriously consider the implications of its healthcare policies to ensure equity and avoid potential financial and reputational damage.

Bowyer Research has issued a notice of exempt solicitation to The Walt Disney Company's shareholders, urging them to vote in favor of a proposal by the National Legal and Policy Center on Disney's 2024 proxy ballot. The proposal calls for a report by December 31, 2024, detailing compensation and health benefit gaps, specifically addressing care related to gender dysphoria and de-transitioning across gender classifications. It also seeks to highlight the associated risks in terms of reputation, competition, operations, and talent recruitment and retention. Bowyer Research criticizes Disney's current stance on gender-affirming care, suggesting that it mischaracterizes the concerns raised and may lead to significant risks, including litigation from employees who regret transition treatments. The solicitation emphasizes the need for Disney to seriously consider the implications of its healthcare policies to ensure equity and avoid potential financial and reputational damage.